Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO).

Published in: Clinical hypertension (2021)

CRIS, KCT0002196 , Registered 3 May 2016.

Keyphrases